ArticleJournal of thoracic disease2022

Extended use of rh-endostatin improves prognosis in patients with advanced non-small cell lung cancer: an analysis of retrospective study.

Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.